内啡肽-1后处理对大鼠心肌缺血再灌注损伤的实验研究

中国临床药理学与治疗学 ›› 2015, Vol. 20 ›› Issue (2): 132-137.

内啡肽-1后处理对大鼠心肌缺血再灌注损伤的实验研究

宗巧凤¹, 程向阳², 于影¹, 张蔚屏¹, 高琴¹, 李正红¹

¹蚌埠医学院生理学教研室,蚌埠 233000,安徽;
²蚌埠医学院第一附属医院麻醉科,蚌埠 233000,安徽

收稿日期:2014-07-11 修回日期:2014-09-05 出版日期:2015-02-26 发布日期:2015-03-20
通讯作者: 李正红,女,博士,硕士生导师,研究方向:心血管生理与病理生理。Tel: 0552-3175071 E-mail: lizhbbmc@163.com
作者简介:宗巧凤,女,硕士研究生, 研究方向:心血管生理与病理生理。Tel: 18355250756 E-mail: 987376537@qq.com
基金资助:
安徽省教育厅自然科学研究重点项目(KJ2011A202);蚌埠医学院科技发展基金重点项目(Bykf13A10);蚌埠医学院研究生创新计划项目(Byycx1307)

Experimental study of endomorphin-1 postconditioning against myocardial ischemia reperfusion injury in rats

ZONG Qiao-feng¹, CHENG Xiang-yang², YU Ying¹, ZHANG Wei-ping¹, GAO Qin¹, LI Zheng-hong¹

¹Department of Physiology, Bengbu Medical College, Bengbu 233000, Anhui, China;
²Department of Anesthesiology,the First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, Anhui, China

Received:2014-07-11 Revised:2014-09-05 Online:2015-02-26 Published:2015-03-20

摘要/Abstract

摘要： 目的: 观察内啡肽-1(EM-1)后处理对大鼠心肌缺血再灌注损伤的影响。方法: 健康雄性SD大鼠48只,随机分为8组:假手术组(S组),缺血再灌组(IR组),缺血后处理组(IPO组),EM-1后处理10、20和 50 μg/kg(EM10、EM20、EM50)三组,EM-1 50 μg/kg+纳洛酮 3 mg/kg 后处理组(EM50+Nal组)、Nal后处理组(Nal组),均 i.v. 给药。结扎冠脉左前降支 30 min,再灌 120 min 造IR模型。全程监测心率(HR)、平均动脉压(MAP)和Ⅱ导联心电图(ECG)。动脉血浆检测丙二醛(MDA)含量及乳酸脱氢酶(LDH)和超氧化物歧化酶(SOD)的活性。结果: 除EM各组再灌注 120 min MAP外,IPO组和EM各组HR、MAP、RPP的下降程度均显著低于IR组(P<0.05,P<0.01);与IR组比较,IPO组和EM-1三个剂量组均使血浆LDH活性降低、MDA含量降低及SOD活性增加(P<0.05,P<0.01),且EM对MDA含量及SOD活性的影响呈剂量依赖;与EM50组比较,EM50+Nal组血浆LDH活性升高、MDA含量增加及SOD活性降低(P<0.05,P<0.01)。结论: EM-1后处理可能是通过激动阿片受体,引起MDA含量降低及SOD活性增加,发挥对心肌缺血再灌注损伤的保护作用。

关键词: 内啡肽-1, 阿片受体, 心肌缺血再灌注, 缺血后处理, 心肌保护

Abstract: AIM: To investigate the effects of endomorphin-1 (EM-1) postconditioning in rats on myocardial ischemia reperfusion injury.METHODS: 48 male Sprague Dawley rats were randomly divided into 8 groups:sham group (S group), ischemia-reperfusion group (IR group), ischemia postconditioning group (IPO group), EM-1 postconditioning groups (10, 20, 50 μg/kg) (EM10, EM20, EM50), EM-1 50 μg/kg+Naloxone 3 mg/kg postconditioning (EM50+Nal group), Naloxone postconditioning group (Nal group). The myocardial ischemia reperfusion injury model was established through occluding the left anterior descending branch of coronary artery for 30 min and reperfusing for 120 min in vivo. Heart rate (HR), mean arterial pressure (MAP), and Ⅱlead electrocardiogram were continuously monitored during the process. The arterial blood sample was obtained to measure plasma content of malondialdehyde(MDA) and the activities of lactate dehydrogenase (LDH), superoxide dismutase(SOD).RESULTS: In addition to the MAP of reperfusion 120 min in EM-1groups, the HR, MAP, RPP of IPO and EM-1 groups were significantly lower than IR group (P<0.05, P<0.01). Compared with IR group, the activity of LDH and content of MDA were decreased and the activity of SOD was increased (P<0.05,P<0.01) in IPO and EM-1 groups after reperfusion. EM-1 produced a dose-related effect on the content of MDA and the activity of SOD. The activity of LDH and content of MDA were higher and the activity of SOD was lower (P<0.01) in EM50+Nal group than in EM50 group after reperfusion.CONCLUSION: EM-1 postconditioning may produce the cardioprotection of myocardial ischemia reperfusion injury by activating opioid receptor, reducing the MDA and increasing the SOD.

Key words: endomorphin-1, opioid receptor, myocardial ischemia reperfusion, ischemia postconditioning, cardioprotection

中图分类号:

宗巧凤, 程向阳, 于影, 张蔚屏, 高琴, 李正红. 内啡肽-1后处理对大鼠心肌缺血再灌注损伤的实验研究[J]. 中国临床药理学与治疗学, 2015, 20(2): 132-137.

ZONG Qiao-feng, CHENG Xiang-yang, YU Ying, ZHANG Wei-ping, GAO Qin, LI Zheng-hong. Experimental study of endomorphin-1 postconditioning against myocardial ischemia reperfusion injury in rats[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 132-137.

参考文献

[1] 孟玉洁,刘保江,苗永民. 阿片类药物后处理对心肌缺血再灌注损伤保护作用的研究进展[J]. 中西医结合心脑血管病杂志,2012,10(5):595-597.
[2] Zadina JE,Hackler L,Ge LJ,et al. A potent and selective endogenous agonist for the mu-opiate receptor [J]. Nature,1997,386(6624):499-502.
[3] Hui R,Wang W,Chen T,et al. Origins of endomorphin-2 immunopositive fibers and terminals in the spinal dorsal horn of the rat [J].Neuroscience,2010,169(1):422-430.
[4] Fichna J,Gach K,Perlikowska R,et al.Novel endomorphin analogues with antagonist activity at the mu-opioid receptor in the gastrointestinal tract [J].Regul Pept,2010,162(1/2/3):109-114.
[5] Anton B,Leff P,Calva JC,et al.Endomorphin 1 and endomorphin2 suppress in vitro antibody formation at ultra-low concentrations: anti-peptide antibodies but not opioid antagonists block the activity [J].Brain Behav Immun,2008,22(6):824-832.
[6] Zhou H,Hou SZ,Luo P,et al.Ginseng protects rodent hearts from acute myocardial ischemia reperfusion injury through GR/ER-activated RISK pathway in an endothelial NOS-dependent mechanism [J].J Ethnopharmacol,2011,135(2):287-298.
[7] Hausenloy DJ,Tsang A,Yellon DM. The reperfusion injury salvage kinase pathway:a common target for both ischemic preconditioning and postconditioning [J]. Trends Cardiovasc Med, 2005, 15(2):69-75.
[8] Yellon DM, Opie LH. Postconditioning for protecttion of the infarcting heart [J]. Lancet, 2006, 367(9509): 456-458.
[9] Zatta AJ,Kin H,Yoshishige D,et al. Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation [J]. Am J Physiol Heart Circ Physiol, 2008,294(3):H1444-H1451.
[10]张鹏, 朱运龙, 王跃民, 等. κ阿片受体激动剂U50488H对大鼠心肌缺血再灌注室性心律失常的影响及作用机制[J]. 中国临床药理学与治疗学,2006, 11(3):251-255.
[11]Chen Z,Li T,Zhang B. Morphine postconditioning protects against reperfusion injury in the isolated rat hearts[J]. J Surg Res,2008,145(2) : 287-294.
[12]Wong GT,Li R,Jiang LL,et al.Remifentanil post-conditioning attenuates cardiac ischemia- reperfusion injury via kappa or delta opioid receptor activation[J]. Acta Anaesthesiol Scand,2010,54(4) : 510 -518.
[13]吴云,顾尔伟,方卫平, 等. 舒芬太尼后处理对在体大鼠心肌缺血再灌注损伤的影响 [J]. 安徽医科大学学报,2011,46(7):652-655.
[14]Savateev AV,Savateeva-Liubimova TN. Apoptosis-universal mechanisms of cell death and survival in ischemia and reperfusion: ways to pharmacological control [J]. Eksp Klin Farmakol,2010,73 (12):44-49.
[15]Xia Q,Qian LB.Cardiac and cerebral ischemia/reperfusion injury and prevention strategies [J].Zhejiang Da Xue Xue Bao Yi Xue Ban,2010,39(6):551-558.
[16]章斌,许智惠,陶正贤. 血管内皮生长因子165通过抑制钙敏感性受体减少缺血/再灌注心肌细胞凋亡 [J]. 中国临床药理学与治疗学,2011,16(1):26-32.
[17]GAO YH,Chen L,Ma YL,et al. Chronic intermittent hypoxia aggravates cardiomyocyte apoptosis in rat ovariectomized model [J]. Chin Med J(Engl),2012,125(17):3087-3092.
[18]刘爱华,石孟琼,杨文雁, 等. 珠子参总皂苷对大鼠心肌缺血/再灌注损伤的保护作用及机制研究 [J]. 中国临床药理学与治疗学,2013, 18(11):1224-1232.